StockData
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF

Inventiva S.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026
$2.98+0.04 (+1.36%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 29, 2026After market close–––
Q4 FY2025
Ended Dec 31, 2025
Feb 17, 2026Before market open–––
Q2 FY2025
Ended Jun 30, 2025
Sep 29, 2025Before market open–––
Q4 FY2024
Ended Dec 31, 2024
Feb 10, 2025After market close–––
Q2 FY2024
Ended Jun 30, 2024
Sep 25, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Mar 27, 2024After market close–––
Q2 FY2023
Ended Jun 30, 2023
Sep 28, 2023After market close–––
Q4 FY2022
Ended Dec 31, 2022
Feb 14, 2023After market close–––
Q2 FY2022
Ended Jun 30, 2022
Sep 22, 2022Before market open–––
Q4 FY2021
Ended Dec 31, 2021
Mar 7, 2022After market close–––

Press releases

Announcements Inventiva filed with the SEC